NEW YORK (GenomeWeb News) – LabCorp said today that it has struck a collaborative agreement with Duke University covering operations at its Biorepository in Kannapolis, NC.
The collaboration will focus on the operations of the facility and management of the samples deposited by Duke University, and by LabCorp's clients and its collaborators.
The company said that when the Biorepository opens later this year it will hold up to 10 million samples and will offer a high-security storage environment and on-site nucleic acid and sample preparation capabilities. The facility will be closely linked to Duke University, the David H. Murdock Core Laboratory Building at the North Carolina Research Campus, and LabCorp's network of routine and esoteric laboratories for discovery and commercial testing.
"The combined capabilities of our organizations through the Biorepository will further our leadership in personalized medicine and will lead to new discoveries and new diagnostic tests that will benefit patient care," LabCorp CEO David King said in a statement.